#ESC2019 Preview: PARAGON-HF Trial
- Cardio
- 03/08/2019
Topline findings from the Phase III PARAGON-HF study have just been announced. Full results of the trial will be presented at the ESC Congress 2019 in September. The PARAGON-HF trial
READ MORETopline findings from the Phase III PARAGON-HF study have just been announced. Full results of the trial will be presented at the ESC Congress 2019 in September. The PARAGON-HF trial
READ MOREToday in healthcare, more emphasis is being placed on treating the patient rather than a particular disease. In this sense, it is not unusual that the line between cardiology and diabetes care has...
READ MOREThe prevalence of Type 2 diabetes has become a public health issue, as the International Diabetes Federation recorded a total of 425 million adults between the ages of 20 and 79 that had diabetes...
READ MOREA study published in JAMA Cardiology aimed to measure the prevalence of silent myocardial infarction (SMI) in patients that have had a sudden cardiac death (SCD) with no other history of coronary...
READ MOREThe benefits of low-dosages of aspirin (75-100mg daily) for the secondary prevention of cardiovascular diseases (CVDs) exceed the risk of bleeding. However, most are still unclear whether a
READ MOREThe most in-depth study in the world on smoking risks to cardiovascular health reveals 17 Australian smokers die each day from heart attacks, strokes and other cardiovascular conditions. The
READ MOREA new study published in JCI Insight confirms the belief that a high intake of carbohydrates is unhealthy, whether a person is trying to lose weight or not. A low-carb, high-fat diet improves...
READ MOREFindings from the American College of Cardiology's Professional Life Survey show that approximately 27% of American cardiologists are burned out, and 49.5% are under stress. The survey is publish
READ MOREIn a new study presented at the 5th European Academy of Neurology (EAN) Congress, it was found that 10% of participants from 35 countries had endured a Near-Death Experience (NDE). Researcher
READ MORETranscatheter aortic valve replacement (TAVR) is widely used to treat aortic stenosis. The treatment approach is approved by the FDA and is recommended in patients with severe symptomatic aortic...
READ MORE